Tag: EXCEED-ET study

Medical illustration showing blood cells and treatment response data from essential thrombocythemia study
New StudiesResearch Digest

New Interferon Treatment Shows Promise for Essential Thrombocythemia Across All Genetic Variants

New North American study shows ropeginterferon alfa-2b-njft achieved 61% complete response rate in essential thrombocythemia patients across all genetic variants.…

By
GMJ Research Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →